The Unanimous Vote Is but the Latest Controversial and Disappointing Action by an ‘Independent’ FDA Advisory Panel
When sales of Tysabri were suspended on February 28, 2005, many critics of the highly controversial MS drug, with potentially fatal side-effects, hoped that would end the saga of a medication that many experts believed should never have been approved in the first place. That, however, was only the beginning of the story.
Full Article by Steve DiJoseph
# posted by madthumbs @ 10:10 AM
